EUVIMEDEUVIMED entdecken
Crossref

AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody–Drug Conjugate Synthesis

Yutaka Matsuda iD, Natsuki Shikida, Noriko Hatada, Kei Yamada, Takuya Seki, Yuichi Nakahara iD, Yuta Endo, Kazutaka Shimbo, Kazutoshi Takahashi iD, Akira Nakayama, Brian A Mendelsohn iD, Tomohiro Fujii und 2 weitere

Organic Letters · 12.07.2024 · 26 (27) · 5597-5601

DOI: 10.1021/acs.orglett.4c00878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic Letters, online erschienen am 19.04.2024. Verfasst von Yutaka Matsuda und 13 weiteren Autor:innen. Beteiligte Einrichtung: Ajinomoto Co., Inc., 1-1, Suzuki-Cho, Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-8681, Japan. Hauptthemen laut MEDLINE: Immunoconjugates, Peptides. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesPeptidesAnimalsHumansMolecular StructureUbiquitins

Substanzen

ImmunoconjugatesPeptidesUbiquitins

Autor:innen und Institutionen

  • Ajinomoto Co., Inc., 1-1, Suzuki-Cho, Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-8681, Japan.
  • Ajinomoto Bio-Pharma Services, 11040 Roselle Street, San Diego, California 92121, United States.

ORCID-Profile: Yutaka Matsuda, Yuichi Nakahara, Kazutoshi Takahashi, Brian A Mendelsohn, Shigeo Hirasawa

Zitieren

APA

Matsuda, Y., Shikida, N., Hatada, N., Yamada, K., Seki, T., Nakahara, Y., Endo, Y., Shimbo, K., Takahashi, K., Nakayama, A., Mendelsohn, B. A., Fujii, T., Okuzumi, T., & Hirasawa, S. (2024). AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody–Drug Conjugate Synthesis. Organic Letters, 26(27), 5597-5601. https://doi.org/10.1021/acs.orglett.4c00878

Vancouver

Matsuda Y, Shikida N, Hatada N, Yamada K, Seki T, Nakahara Y, et al. AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody–Drug Conjugate Synthesis. Organic Letters. 2024;26(27):5597-5601. doi:10.1021/acs.orglett.4c00878

BibTeX
@article{Matsuda2024,
  author = {Matsuda, Yutaka and Shikida, Natsuki and Hatada, Noriko and Yamada, Kei and Seki, Takuya and Nakahara, Yuichi and Endo, Yuta and Shimbo, Kazutaka and Takahashi, Kazutoshi and Nakayama, Akira and Mendelsohn, Brian A and Fujii, Tomohiro and Okuzumi, Tatsuya and Hirasawa, Shigeo},
  title = {AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody–Drug Conjugate Synthesis},
  journal = {Organic Letters},
  year = {2024},
  volume = {26},
  number = {27},
  pages = {5597--5601},
  doi = {10.1021/acs.orglett.4c00878}
}
Kostenlos starten →